Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's ...

GOTHENBURG, SWEDEN / ACCESSWIRE / November 13, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November ...

On Monday, Summit Therapeutics Inc (SMMT) stock saw a modest uptick, ending the day at $21.77 which represents a slight increase of $0.36 or 1.68% from the prior close of $21.41. The stock opened at ...

AppLovin's stock had its best day ever Thursday, rising 46% following the company's latest earnings, and it gained another 18% in Friday's session. That could reflect investor perception of how far ...

Biopharma stocks are rarely suitable for short-term investing, so hold onto them. Summit Therapeutics may have a powerful new ...

Despite the potential in oncology, BNTX's current valuation is high relative to its non-COVID revenue prospects, warranting a ...

Riley Securities’ Next-Gen Tissue Delivery Modalities Virtual Summit, virtual, including a fireside chat ... be archived on the Company's website for at least 30 days. Voyager Therapeutics, Inc.

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are covering the firm, Marketbeat Ratings reports. Eight ...

Join STAT to explore how the biopharma industry is advancing outcome-based multimodal therapeutics on Nov. 22.

Now this is a fine way to begin a week on the stock market. Summit Therapeutics (NASDAQ: SMMT) saw its stock price rise ...

Fintel reports that on November 4, 2024, JMP Securities initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...